Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$3.85 +0.33 (+9.50%)
As of: Nov 11, 2026 · 3:02 PM EST

Verrica Pharmaceuticals (VRCA) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Verrica Pharmaceuticals (VRCA) posted Return on Capital Employed [ROCE] of -189.69% for Q2 2026, up 149.47 percentage points from -339.16% a year earlier but down 138.20 percentage points from the prior quarter.

Analysis

Verrica Pharmaceuticals (VRCA) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Verrica Pharmaceuticals' Return on Capital Employed [ROCE] came in at -35.63%, up 134.03 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +90.67 percentage points (FY2020 to FY2025).
  • In prior years, Verrica Pharmaceuticals' Return on Capital Employed [ROCE] was -169.66% in FY2024 (-27.12 pp), -142.54% in FY2023 (-106.42 pp), -36.12% in FY2022 (+63.32 pp) and -99.43% in FY2021 (+26.87 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -454.03% in Q4 2024 to a high of -38.81% in Q1 2023 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last four quarters, with an average year-over-year change of +9.68 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2025, with a gain of 409.85 percentage points; the weakest was Q4 2024, with a drop of 363.14 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -51.50% (Q1 2026), -44.19% (Q4 2025) and -147.86% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Verrica Pharmaceuticals 60.47 Mn -22.58 Mn 5.43 Mn -189.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -189.69%
Mar 31, 2026 -51.50%
Dec 31, 2025 -44.19%
Sep 30, 2025 -147.86%
Jun 30, 2025 -339.16%
Mar 31, 2025 -295.58%
Dec 31, 2024 -454.03%
Sep 30, 2024 -362.11%
Jun 30, 2024 -206.76%
Mar 31, 2024 -141.55%
Dec 31, 2023 -90.89%
Sep 30, 2023 -71.50%
Jun 30, 2023 -39.32%
Mar 31, 2023 -38.81%
Dec 31, 2022 -48.98%
Sep 30, 2022 -44.26%
Jun 30, 2022 -168.55%
Mar 31, 2022 -123.52%
Dec 31, 2021 -80.52%
Sep 30, 2021 -72.54%
API Access

Verrica Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VRCA&period=max&api_key=YOUR_API_KEY